Correction to: Augmented EPR effect post IRFA to enhance the therapeutic efficacy of arsenic loaded ZIF-8 nanoparticles on residual HCC progression (Journal of Nanobiotechnology, (2022), 20, 1, (34), 10.1186/s12951-021-01161-3)

Xuehua Chen; Yongquan Huang; Hui Chen; Ziman Chen; Jiaxin Chen; Hao Wang; Dan Li; Zhongzhen Su

ArticleOPEN ACCESS

Correction to: Augmented EPR effect post IRFA to enhance the therapeutic efficacy of arsenic loaded ZIF-8 nanoparticles on residual HCC progression (Journal of Nanobiotechnology, (2022), 20, 1, (34), 10.1186/s12951-021-01161-3)

Journal of Nanobiotechnology

DOI: 10.1186/s12951-022-01386-w

1Citations

1Readers

Abstract

Following publication of the original article [1], the authors reported that Fig. 4C was incorrect. The corrected Fig. 4 and the figure caption are given below. The corrections do not affect the results and conclusions. All authors agree to these corrections and apologize for these errors.

Cite

CITATION STYLE

APA

Chen, X., Huang, Y., Chen, H., Chen, Z., Chen, J., Wang, H., … Su, Z. (2022, December 1). Correction to: Augmented EPR effect post IRFA to enhance the therapeutic efficacy of arsenic loaded ZIF-8 nanoparticles on residual HCC progression (Journal of Nanobiotechnology, (2022), 20, 1, (34), 10.1186/s12951-021-01161-3). Journal of Nanobiotechnology. BioMed Central Ltd. https://doi.org/10.1186/s12951-022-01386-w

Correction to: Augmented EPR effect post IRFA to enhance the therapeutic efficacy of arsenic loaded ZIF-8 nanoparticles on residual HCC progression (Journal of Nanobiotechnology, (2022), 20, 1, (34), 10.1186/s12951-021-01161-3)

Abstract

Cite

Register to see more suggestions